Filing Details
- Accession Number:
- 0000899140-24-000705
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2024-07-10 11:11:45
- Reporting Period:
- 2024-06-23
- Accepted Time:
- 2024-07-10 11:11:45
- Original Submission Date:
- 2024-06-25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1638287 | Neurobo Pharmaceuticals Inc. | NRBO | Pharmaceutical Preparations (2834) | 472389984 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1799260 | Dong-A St Co., Ltd | 64, Cheonho-Daero Dongdaemun-Gu Seoul M5 02587 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-06-23 | 2,544,530 | $3.93 | 5,348,229 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This amendment to Form 4 is being filed by the reporting person to correct a scrivener's error in the Form 4 filed by the reporting person on June 25, 2024 (the "Original Form 4"). The Original Form 4 incorrectly reported a $3.13 price per share of Common Stock acquired by the reporting person in the subject transaction. As reported in this amendment to Form 4, the price per share of Common Stock acquired by the reporting person in the subject transaction was $3.93 per share.